NCIC Clinical Trials Group: Lung Neoplasms trials

The registry lists 14 Lung Neoplasms studies with NCIC Clinical Trials Group as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 1 6Phase 2 4Phase 3 7No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic CancerCompletedNCT01000025Phase 3Results posted
• Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00795340Phase 3Results posted
• MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous ChemotherapyCompletedNCT01068587Phase 1/2
• MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00869752Phase 1/2
• OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsCompletedNCT00471432Phase 1
• Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT00346320Not applicable
• AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal CancerCompletedNCT00343408Phase 1
• Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00245154Phase 2/3
• AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)CompletedNCT00107250Phase 1
• Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT00006229Phase 2/3
• Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00006036Phase 1
• Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung CancerCompletedNCT00003685Phase 3
• Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung CancerCompletedNCT00003011Phase 3
• Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically RemovedCompletedNCT00002583Phase 3